Frances Oldham Kelsey papers, 1890-2016 (Library of Congress Finding Aid)

Access restrictions apply.Some or all content stored offsite.

Container	Contents

	Part II: Subject File, 1902-2012 (continued)
BOX II:191		Selenium See Container II:206, Toxicology
BOX II:191		Semustine See Containers II:180-II:182, National Cancer Institute
BOX II:191		Separation of functions, 1980
BOX II:191		Serc (Drug), 1968-1969, 1996, undated
BOX II:191		Serotonin, 1963-1964, 1970, undated
BOX II:191		Shepard, Thomas H., Compendium of Teratogens, 1971, 1996
BOX II:192		Shopsin, Baron, 1991
BOX II:192		Sigma Xi, The Scientific Research Society, U.S. Food and Drug Administration club, 1982-1987, 1996-1997, 2012
BOX II:192		Sjoerdsma, Albert, honorary banquet for, 1989
BOX II:192		Society of Nuclear Medicine, 1960-1973, 1998, undated
BOX II:192		Society of Toxicology, 1964, undated
BOX II:192		Special Survey: Sponsors and Investigators of Clinical Investigations, report on
BOX II:192			1970-1980
				(6 folders)
BOX II:192			Undated
				(1 folder)
BOX II:193				(1 folder)
BOX II:193		Spermacides/trichamonacides, 1972-1986
BOX II:193		Staff College Executive Committee, 1989-1990
BOX II:193		Stem cells, 2000-2001
BOX II:193		Stolpen, Adam, “Allergic Drug Reactions: Where Does the Duty Lie?” circa 1970, 1997
BOX II:193		Straus, Marc J., 1980-1982, 1996-1997, undated
			(4 folders)
BOX II:193		Submission management and review tracking, 1995
BOX II:193		Summers, William K., 1987-1989, 1997-1999, undated
BOX II:193		Supplements, memoranda by Kelsey, 1968
BOX II:194		Suprofen, 1987
BOX II:194		Tamoxifen, report, 1997
BOX II:194		Taussig, Helen B., 1977, 1988, 1994, 2001, undated
BOX II:194		Teplick, Steven K., hearing at U.S. Food and Drug Administration, 1993-1999
BOX II:194		Teratology
BOX II:194			General, 1946, 1960-1962, 1968-1997, undated
				(2 folders)
BOX II:194			Screening procedures
BOX II:194				1962-1969
					(3 folders)
BOX II:195				circa 1960s
BOX II:195				1970-1995, undated
					(9 folders)
BOX II:195		Teratology Society, 1961, 1974, 1984-1988, 1998, 2011, undated
BOX II:196		Tetracyclines/sulfonamides, 1961-1979, undated
BOX II:196		Thalidomide
BOX II:196			Archer, John D., 1960-1979, 1986, 1996-1998, undated
				(2 folders)
BOX II:196			Bell, Peter D., “The Thalidomide Case,” 1963, 1995
BOX II:196			Broadsides, “Drug Detective, Frances O. Kelsey, M.D.,” circa 1963 See also Oversize
BOX II:196			Burkholz, Herbert, “Giving Thalidomide a Second Chance,” 1997
BOX II:196			Chick studies, 1962-1969
BOX II:196			CIBA Pharmaceutical Co., 1962, undated
BOX II:196			Cost recovery for thalidomide for sponsor-investigator investigational new drugs, 1996, undated
BOX II:196			Deformities, no evidence of, 1962-1963
BOX II:196			Drug deformities
BOX II:196				Foundation for Medical Research Perinatal Study, Philadelphia, Pa., 1962-1966
BOX II:196				Northrup, Harriett E., 1962
BOX II:197			Epstein, Beryl, and Samuel Epstein, Who Says You Can’t?, 1968
BOX II:197			Exhibits, 1956-1961
BOX II:197			FDA Consumer Memo andFDA Fact Sheet, 1968, 1974
BOX II:197			FDA Dermatological and Ophthalmic Drugs Advisory Committee, 1996-1997
BOX II:197			FDA Thalidomide Working Group
BOX II:197				1961, 1988-1998
					(7 folders)
BOX II:198				1999-2001
					(4 folders)
BOX II:198				Undated and fragments
BOX II:198			FDA/National Institutes of Health Workshop, “Thalidomide: Potential Benefits and Risks,” 1997
				(1 folder)
BOX II:199				(2 folders)
BOX II:199			General
BOX II:199				1960-1979
					(6 folders)
BOX II:200				1980-2002, undated
					(7 folders)
BOX II:200			Inspection report for SKG #5627, 1962
BOX II:201			Investigation of Trent Busby, 1961-1962
BOX II:201			Isomers and others, 1961-1963, 1970, 1979-1990, undated
				(2 folders)
BOX II:201			Kevadon
BOX II:201				Memoranda, 1960-1962
					(3 folders)
BOX II:201				Microfiche of documents from unapproved new drug applications 12611 and 12711 (thalidomide) obtained through Freedom of Information Act request of John Carey, 1978
					Microfiche shelf no. 22,656
BOX II:201				Telephone calls, 1962-1963
					(2 folders)
BOX II:201			Legal cases
BOX II:201				Diamond, Thomas David, 1962, 1969
BOX II:201				Grünenthal GmbH
BOX II:201					Brochure material, William S. Merrell Co., circa 1961
BOX II:202					Correspondence
BOX II:202						Distillers Co. (Biochemicals), circa 1959-1962
BOX II:202						National Drug Co., 1961-1962
							(2 folders)
BOX II:202						William S. Merrell Co., 1961-1962
							(3 folders)
BOX II:202					Kelsey memorandum, 1994
BOX II:202				Marshall, Alan David, 1962
BOX II:202				McCarrick v. Richardson-Merrell, includes testimony of Kelsey, 1971
BOX II:202				McKenna v. United States, 1995-1996
BOX II:203				Rowe, Lynette Suzanne, 2012
BOX II:203				United States v. John Doe, 1962
BOX II:203			Material received through Freedom of Information Act request of Burton L. Appleton, 1960-1961, 1995
BOX II:203			Names marketed under, undated
BOX II:203			Peripheral neuritis, 1961-1973, 1984, 1993-1997
BOX II:203			Popular and semipopular articles, 1963
BOX II:203			Press coverage and Kelsey, 1962
BOX II:203				Numbered
BOX II:203					Vols. 3-9
						(5 folders)
BOX II:204					Vols. 11-14
						(3 folders)
BOX II:204				Unnumbered
BOX II:204					Vols. A-D
						(4 folders)
BOX II:205					Vols. E-M
						(9 folders)
BOX II:206			Smith, Kline & French Laboratories, Philadelphia, Pa., 1962, 1995
				(2 folders)
BOX II:206			Survey of city health workers, 1962
BOX II:206			Taussig, Helen B. See Container II:194, same heading
BOX II:206		Therakos, Inc. See Container II:186, Oxsoralen
BOX II:206		Third-party certification, 1994-2000
			(3 folders)
BOX II:206		Third-party notification, 1979-1984, undated
			(2 folders)
BOX II:206		Thyroid: diseases, iodine, iodine 131, and thyroxine, 1960-1972, 1978-1988, 1998-2001, undated
BOX II:206		Toxic shock syndrome, 1980-1984
Next Page »

Frances Oldham Kelsey papers, 1890-2016

Contents List